About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 762874, 7 pages
http://dx.doi.org/10.1155/2012/762874
Research Article

Automatic Reading of ANCA-Slides: Evaluation of the AKLIDES System

Laboratory of Clinical Immunology, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands

Received 2 October 2012; Accepted 10 October 2012

Academic Editor: Dimitrios P. Bogdanos

Copyright © 2012 Jan Damoiseaux et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. W. Cohen Tervaert and J. Damoiseaux, “Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up?” Clinical Reviews in Allergy and Immunology. In press. View at Publisher · View at Google Scholar
  2. J. F. Fries, G. G. Hunder, D. A. Bloch et al., “The American college of rheumatology 1990 criteria for the classification of vasculitis: summary,” Arthritis and Rheumatism, vol. 33, no. 8, pp. 1135–1136, 1990. View at Scopus
  3. J. C. Jennette, R. J. Falk, K. Andrassy et al., “Nomenclature of systemic vasculitides: proposal of an international consensus conference,” Arthritis and Rheumatism, vol. 37, no. 2, pp. 187–192, 1994. View at Scopus
  4. R. Watts, S. Lane, T. Hanslik et al., “Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies,” Annals of the Rheumatic Diseases, vol. 66, no. 2, pp. 222–227, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Savige, D. Gillis, E. Benson et al., “International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA),” American Journal of Clinical Pathology, vol. 111, no. 4, pp. 507–513, 1999. View at Scopus
  6. H. K. Choi, S. Liu, P. A. Merkel, G. A. Colditz, and J. L. Niles, “Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies,” Journal of Rheumatology, vol. 28, no. 7, pp. 1584–1590, 2001. View at Scopus
  7. E. P. Gall, “Immunotesting for diagnosis in rheumatic diseases,” Archives of Internal Medicine, vol. 149, no. 11, pp. 2401–2402, 1989. View at Scopus
  8. R. Hiemann, T. Büttner, T. Krieger, D. Roggenbuck, U. Sack, and K. Conrad, “Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells,” Autoimmunity Reviews, vol. 9, no. 1, pp. 17–22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. G. M. C. Damoiseaux, M. C. Slot, M. Vaessen, C. A. Stegeman, P. Van Paassen, and J. W. C. Tervaert, “Evaluation of a new fluorescent-enzyme immuno-assay for diagnosis and follow-up of ANCA-associated vasculitis,” Journal of Clinical Immunology, vol. 25, no. 3, pp. 202–208, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. M. V. Talor, J. H. Stone, J. Stebbing, J. Barin, N. R. Rose, and C. L. Burek, “Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA),” Clinical and Experimental Immunology, vol. 150, no. 1, pp. 42–48, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Melegari Bonaguri C, A. Russo, B. Luisita, T. Trenti, and G. Lippi, “A comparative study on the reliability of an automated system for the evaluation of cell-based indirect immunofluorescence,” Autoimmunity Reviews, vol. 11, pp. 713–716, 2012. View at Publisher · View at Google Scholar
  12. J. G. M. C. Damoiseaux and J. W. Cohen Tervaert, “From ANA to ENA: how to proceed?” Autoimmunity Reviews, vol. 5, no. 1, pp. 10–17, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Damoiseaux, J. Austen, and J. W. Cohen Tervaert, “ANCA diagnostics in clinical practice: new developments,” in Advances in the Diagnosis and Treatment of Vasculitis, L. M. Amezcua-Guerra, Ed., pp. 3–18, Intech, Rijeka, Croatia, 2012.
  14. P. Vermeersch, D. Blockmans, and X. Bossuyt, “Use of likelihood ratios can improve the clinical usefulness of enzyme immunoassays for the diagnosis of small-vessel vasculitis,” Clinical Chemistry, vol. 55, no. 10, pp. 1886–1888, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Birck, W. H. Schmitt, I. A. Kaelsch, and F. J. Van Der Woude, “Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review,” American Journal of Kidney Diseases, vol. 47, no. 1, pp. 15–23, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Tomasson, P. C. Grayson, A. D. Mahr, M. LaValley, and P. A. Merkel, “Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis—a meta-analysis,” Rheumatology, vol. 51, pp. 100–109, 2012. View at Publisher · View at Google Scholar
  17. M. M. Boomsma, J. G. M. C. Damoiseaux, C. A. Stegeman et al., “Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis,” Journal of Immunological Methods, vol. 274, no. 1-2, pp. 27–35, 2003. View at Publisher · View at Google Scholar · View at Scopus